SCHEMBL17437535

SCHEMBL17437535

Nc1ncnn1-c1nc2cnccc2n1Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 1/20 0.43
▸ ALDH1A1 P00352 5/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ RPS6KA5 O75582 2/20 0.40
▸ MAPT P10636 1/20 0.39
▸ HTR3A P46098 1/20 0.39
▸ POLB P06746 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ SOS1 Q07889 2/20 0.38
▸ LMNA P02545 3/20 0.38
▸ CYP1A2 P05177 3/20 0.38
▸ CYP2C9 P11712 3/20 0.38
▸ CYP2C19 P33261 3/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HBB P68871 1/20 0.38
▸ CYP11B2 P19099 1/20 0.37
▸ TNF P01375 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17437495 0.89 HTR3A (0.41) BRD4KDM4ERPS6KA5MAPTHTR3A
SCHEMBL17437404 0.81 RPS6KA5 (0.47) ALDH1A1KDM4ERPS6KA5MAPTPOLB
SCHEMBL17437386 0.81 RPS6KA5 (0.49) ALDH1A1RPS6KA5CYP1A2CYP2C9CYP2C19
SCHEMBL17437408 0.80 RPS6KA5 (0.41) BRD4ALDH1A1KDM4ERPS6KA5MAPT
SCHEMBL17437439 0.77 RPS6KA5 (0.45) ALDH1A1KDM4ERPS6KA5MAPTPOLB
SCHEMBL17437575 0.72 RPS6KA5 (0.48) ALDH1A1RPS6KA5CYP1A2CYP2C9CYP2C19
SCHEMBL17437519 0.71 RPS6KA5 (0.37) RPS6KA5
SCHEMBL17437517 0.71 RPS6KA5 (0.37) RPS6KA5
SCHEMBL17437462 0.71 LTB4R (0.33) RPS6KA5HTTLMNACYP1A2CYP2C9
SCHEMBL17437385 0.70 RPS6KA5 (0.51) ALDH1A1KDM4ERPS6KA5MAPTCYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2017-02-23 — — US disclosed
US-9512120-B2 Microbicidally active imidazopyridine derivatives SYNGENTA PARTICIPATIONS AG (CH) 2016-12-06 — — US disclosed
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2016-01-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 BRD4 1163/4885ALDH1A1 928/4885KDM4E 1452/4885
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 BRD4 1163/4885ALDH1A1 928/4885KDM4E 1452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback